Register to receive the latest information from COPAXONE®.
Your privacy is important to us and the information you provide will be handled in accordance with our Privacy Notice.
I authorize Teva Pharmaceuticals USA, Inc. (“Teva”), its affiliates and companies working with Teva to contact me by direct mail, email, telephone, and electronic message (including autodialed and prerecorded calls and messages) for marketing purposes, such as to provide me with information, offers and promotions regarding relapsing multiple sclerosis, Teva products, and programs, to conduct market research or surveys, and to use my information to develop future products, services and programs. I understand that I may choose to no longer receive further communications from Teva by following the unsubscribe instructions on the communication.
Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.
Apple is a registered trademark of Apple Inc. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.
You are about to leave COPAXONE.com and enter a website operated by a third party.
Would you like to continue?
The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?